Shigenori Ohkawa Free People Check 

( I'm Shigenori Ohkawa)

Loading...

Images of Shigenori Ohkawa

(0 from 0 )

News

(1 - 4 from 30
)

Takeda and Heptares Ink Drug Discovery Deal for CNS Diseaseswww.genengnews.com › news › takeda-and-heptares-ink-drug-discovery-d...

www.genengnews.com
Apr 11, · ... the pharmacological conformations of GPCRs as they exist in their natural cellular environments,” comments Takeda CSO Shigenori Ohkawa.

Takeda biomarker deal for Actos in Alzheimer's - PharmaTimeswww.pharmatimes.com › news › takeda_biomarker_deal_for_actos_in_alz...

www.pharmatimes.com
Jan 11, · Shigenori Ohkawa, chief scientific officer at Takeda, said there is "intense interest within the medical community in identifying treatments ...

Takeda signs schizophrenia deal with Intra-Cellular - PharmaTimeswww.pharmatimes.com › news › takeda_signs_schizophrenia_deal_with_in...

www.pharmatimes.com
Mar 4, · Shigenori Ohkawa, Takeda's chief scientific officer, said the deal will "enhance our central nervous system pipeline", claiming that PDE1 ...

| ITI, Takeda in collaboration

www.centerwatch.com
Mar 02, · ITI, Takeda in collaboration Thursday, March 3, :40 PM through this collaboration," said Shigenori Ohkawa, chief scientific officer for Takeda.
Save as document
+1